Product Profiles

Article

Femtosecond platform

Femtosecond platform

The systems operate at pulse frequencies in the megahertz range and use very low pulse energy. This enables excellent visual outcomes and faster recovery.

For further information please visit http://www.femtoldv.com/

25G cannula

The cannula has a short bevel, meaning it can fully enter the needle tip into the tumour. The diagnostic yield is higher due to the superior cellularity of the biopsy.

For more information please contact info@geuder.de

HD-OCT platform

The Cirrus HD-OCT features a retina application that provides Advanced Retinal Pigment Epithelium (RPE) analysis, This mean the clinicians can objectively monitor changes in dry AMD.

RPE elevation, area and volume can also be tracked with the application and can identify and measure the area of transparent regions in the RPE.

Please visit http://www.meditec.zeiss.com/cirrus/ for more information

Presbyopia treatment system

The system uses bi-aspheric multifocal ablation profiles, enabling an optimum relationship between near and distance vision. It works by directing the dominant eye on distance vision and directs the nondominant eye towards near vision.

Rapid visual recovery is possible at all visual distances with the PresbyMAX and is welltolerated in uncorrected conditions. The system is ideal for patients who would like excellent distance vision. Ocular defects such as myopia, hyperopia and astigmatism can be corrected with the PresbyMAX.

For further details please visit http://www.eye-tech-solutions.com/

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.